CD8A and infection: While subcutaneous vaccinations with CD8 T cell EPs protected mice from low-dose (5 × 103 PFU) SARS-CoV-2 infection, it failed to protect against high-dose (2 × 104 PFU) infection despite substantially lowering lung viral load.